Close Menu

NEW YORK – Bionano Genomics has filed regulatory documents for a public offering of up to $30 million of its common stock and warrants to purchase its common stock.

The genome mapping firm also amended its loan agreement with Innovatus Life Science Lending Fund on March 6 and will make prepayments on the principal totaling $5 million and pay fees of $300,000. Moreover, Bionano registered a resale of approximately 1.1. million shares of its common stock on behalf of Innovatus.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post writes that the approval in the US of a SARS-CoV-2 vaccine will be up to Peter Marks, a career official at the Food and Drug Administration.

According to ScienceInsider, the US National Academies of Science, Engineering, and Medicine is planning a study of racism in academic research.

NPR reports the US loan to Eastman Kodak to boost domestic pharmaceutical production is on pause following insider trading allegations.

In Cell this week: blood immune cell changes in COVID-19 patients and spatial transcriptomics in Alzheimer's disease.